Target intelligence / Profile preview

Undecaprenyl pyrophosphate carrier cycle (UPP cycle)

Target
UPP cycle
Molecular classification
Enzyme, Transporter, Metabolic pathway
01

Overview

The undecaprenyl pyrophosphate carrier cycle, also known as the Lipid II cycle, is a fundamental pathway in bacteria responsible for transporting cell wall precursors across the cytoplasmic membrane (Müller et al., 2017, Nature Communications). It utilizes a C55-isoprenoid lipid carrier, undecaprenyl phosphate (bactoprenol), to shuttle hydrophilic peptidoglycan building blocks from the cytoplasm to the periplasmic space. Key enzymatic steps include the formation of Lipid I and Lipid II intermediates, which are then translocated across the membrane by flippases such as MurJ (Sham et al., 2014, Science). Following the incorporation of the precursors into the peptidoglycan layer, the lipid carrier is released as undecaprenyl pyrophosphate and must be dephosphorylated by enzymes like UppP (BacA) to be recycled (El Ghachi et al., 2004, JBC). This cycle is a major target for antibiotics; for instance, bacitracin inhibits the dephosphorylation step, while glycopeptides like vancomycin and novel agents like teixobactin bind directly to the lipid-linked intermediates to halt cell wall assembly (Stone & Strominger, 1971, PNAS; Ling et al., 2015, Nature). Because this pathway is essential for bacterial survival and lacks a direct human counterpart, it remains a high-priority target for the development of new antimicrobial therapies.

Other names
Lipid II cycleBactoprenol cycleC55-isoprenoid cyclePeptidoglycan precursor transport cycleUndecaprenyl phosphate recycling pathway
02

Mechanism of action

Inhibition of undecaprenyl pyrophosphate dephosphorylation, sequestration of lipid-linked peptidoglycan precursors (Lipid I and Lipid II), and inhibition of flippase-mediated translocation across the cytoplasmic membrane.

03

Biological functions

Cell wall biosynthesisPeptidoglycan synthesisLipid carrier recyclingBacterial cell envelope maintenanceTransmembrane precursor transport
04

Disease associations

InfectionBacterial infection
05

Safety considerations

Nephrotoxicity (associated with systemic bacitracin use)Development of antimicrobial resistance (e.g., via UppP/BacA overexpression)Limited efficacy against Gram-negative bacteria due to outer membrane permeability barriersPotential for injection site reactions with peptide-based inhibitors
06

Interacting drugs

Bacitracin

7 more in the full profile.

07

Biomarkers

Accumulation of UDP-MurNAc-pentapeptideBacterial cell lysisInhibition of peptidoglycan polymer formationDepletion of membrane-associated undecaprenyl phosphate

Beyond the preview

Go deeper on Undecaprenyl pyrophosphate carrier cycle (UPP cycle).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Undecaprenyl pyrophosphate carrier cycle (UPP cycle).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call